Delivery Order SPE2DR25D3103-SPE2DR26F9V56
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count) with a ceiling value of $7,348.24. This firm fixed-price delivery order, with an ultimate completion date of December 30, 2025, represents a non-competitive set-aside award executed under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999.99 million through...
- The Defense Logistics Agency awarded a delivery order valued at $7,718.44 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The work will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) valued at $1,479.08 under a firm fixed-price contract with an ultimate completion date of October 29, 2025. The award is non-competitive and represents a child order issued against the contractor's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $24,468 delivery order to AmerisourceBergen Drug Corp on December 5, 2024, for the supply of Atovaquone-Proguanil 250-100 tablets in quantities of 100, with an ultimate completion date of December 6, 2024. This contract represents a firm fixed price, competitively awarded delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial medication commonly used for...
- The Defense Logistics Agency awarded a delivery order valued at $15,817.44 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) on December 4, 2025, with completion scheduled for December 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial medication commonly used for malaria prophylaxis and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets in a quantity of 100 units. This is a firm fixed-price delivery order valued at $10,073.70 with an ultimate completion date of August 15, 2025. The contract is not set-aside and was competitively awarded. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, the corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,492.71 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) on November 4, 2025, with completion scheduled for November 5, 2025. This non-competitive delivery order utilizes firm fixed-price terms and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $1,586.54 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 tablets in a quantity of 100 units. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of September 11, 2025, and represents a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The product being...
- The Defense Logistics Agency awarded a delivery order valued at $3,153.20 to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Atovaquone-Proguanil 250-100 (100 tablets). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of December 19, 2025. The order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,343.16 to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. The contract, which is firm fixed price with an ultimate completion date of April 24, 2025, carries no set-aside designation and was competitively awarded. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9V56Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Atovaquone-Proguanil 250-100 tablets (100 count) valued at $2,814.68. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was competitively procured on a full and open basis. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with a completion date of January 8, 2026. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is the prime contractor on this award, with its parent company being Cencora, Inc. (doing business as AmerisourceBergen). The company serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems, and demonstrates extensive capability in fulfilling government pharmaceutical supply needs across multiple therapeutic domains. The Atovaquone-Proguanil antimalarial medication being delivered supports the Defense Health Agency and other federal healthcare systems' operational and preventive medicine requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 1/6/26 |